References
- Mistry N, Nolan LS, Saeed SR, Forge A, Taylor RR. Cochlear implantation in the mouse via the round window: effects of array insertion. Hear Res 2014;312:81–90.
- Adunka O, Kiefer J, Unkelbach MH, Lehnert T, Gstoettner W. Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulation. Laryngoscope 2004;114:1237–41.
- Gifford RH, Revit LJ. Speech perception for adult cochlear implant recipients in a realistic background noise: effectiveness of preprocessing strategies and external options for improving speech recognition in noise. J Am Acad Audiol 2010;21:441–51; quiz 87–8.
- Barbara M, Mattioni A, Monini S, Chiappini I, Ronchetti F, Ballantyne D, et al. Delayed loss of residual hearing in Clarion cochlear implant users. J Laryngol Otol 2003;117:850–3.
- Hillman TM, Arriaga MA, Chen DA. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops? Laryngoscope 2003;113:1903–7.
- Trune DR, Canlon B. Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken) 2012;295:1928–43.
- Huang CQ, Tykocinski M, Stathopoulos D, Cowan R. Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants Int 2007;8:123–47.
- James DP, Eastwood H, Richardson RT, O’Leary SJ. Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol 2008;13:86–96.
- Chang A, Eastwood H, Sly D, James D, Richardson R, O’Leary S. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67–72.
- Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear 2007;28:361–9.
- Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007;28:842–9.
- Maria PL, Gluth MB, Yuan Y, Atlas MD, Henry Blevins N. Hearing preservation surgery for cochlear implantation: a meta-analysis. Otol Neurotol 2014;35:e256–69.
- Choi CH, Oghalai JS. Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hear Res 2005;205:193–200.
- O’Leary SJ, Monksfield P, Kel G, Connolly T, Souter MA, Chang A, et al. Relations between cochlear histopathology and hearing loss in experimental cochlear implantation. Hear Res 2013;298:27–35.
- Braun S, Ye Q, Radeloff A, Kiefer J, Gstoettner W, Tillein J. Protection of inner ear function after cochlear implantation: compound action potential measurements after local application of glucocorticoids in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec 2011;73:219–28.
- Haake SM, Dinh CT, Chen S, Eshraghi AA, Van De Water TR. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res 2009;255:22–32.
- Van De Water TR, Abi Hachem RN, Dinh CT, Bas E, Haake SM, Hoosien G, et al. Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms. Cochlear Implants Int 2010;11:42–55.
- Tornabene SV, Sato K, Pham L, Billings P, Keithley EM. Immune cell recruitment following acoustic trauma. Hear Res 2006;222:115–24.
- Kang SY, Colesa DJ, Swiderski DL, Su GL, Raphael Y, Pfingst BE. Effects of hearing preservation on psychophysical responses to cochlear implant stimulation. J Assoc Res Otolaryngol 2010;11:245–65.
- Takumi Y, Nishio SY, Mugridge K, Oguchi T, Hashimoto S, Suzuki N, et al. Gene expression pattern after insertion of dexamethasone-eluting electrode into the Guinea pig cochlea. PLoS ONE 2014;9:e110238.